M C Michel|L C Rump - JoVE Visualize

Showing results (141-150 of 343) with videos related to

Pageof 35

Sort By:

Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1995

Classification of alpha 1-adrenoceptor subtypesM C Michel, B Kenny, D A Schwinn

Life Sciences|January 1, 1994

Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist?R Büscher, P A Insel, M C Michel

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 14, 2016

Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertensionS A Potthoff, S Stamer, K Grave, et al.

Pflugers Archiv : European Journal of Physiology|December 11, 1999

Is bradykinin a mediator of renal neuropeptide Y effects?A Bischoff, A Neumann, A Dendorfer, et al.

Molecular Pharmacology|January 1, 1990

Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonistsJ R Jasper, M C Michel, P A Insel

Canadian Journal of Physiology and Pharmacology|March 29, 2000

Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonistsS Dove, M C Michel, S Knieps, et al.

Life Sciences|September 19, 2000

Comparison of [3H]tamsulosin and [3H]prazosin binding to wild-type and constitutively active alpha1B-adrenoceptorsP Hein, M Goepel, S Cotecchia, et al.

Biochemical Pharmacology|October 1, 1987

Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonistsM C Michel, A Rother, C Hiemke, et al.

The Journal of Endocrinology|September 1, 1985

Time-dependent effects of oestradiol and progesterone on hypothalamic catecholamine turnover in ovariectomized ratsC Hiemke, D Bruder, M C Michel, et al.

The Journal of Biological Chemistry|August 29, 1998

ATP activates cAMP production via multiple purinergic receptors in MDCK-D1 epithelial cells. Blockade of an autocrine/paracrine pathway to define receptor preference of an agonistS R Post, L C Rump, A Zambon, et al.

Pageof 35

Showing results (141-150 of 343) with videos related to

Sort By:

Pageof 35

Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1995

Classification of alpha 1-adrenoceptor subtypesM C Michel, B Kenny, D A Schwinn

Life Sciences|January 1, 1994

Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist?R Büscher, P A Insel, M C Michel

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 14, 2016

Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertensionS A Potthoff, S Stamer, K Grave, et al.

Pflugers Archiv : European Journal of Physiology|December 11, 1999

Is bradykinin a mediator of renal neuropeptide Y effects?A Bischoff, A Neumann, A Dendorfer, et al.

Molecular Pharmacology|January 1, 1990

Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonistsJ R Jasper, M C Michel, P A Insel

Canadian Journal of Physiology and Pharmacology|March 29, 2000

Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonistsS Dove, M C Michel, S Knieps, et al.

Life Sciences|September 19, 2000

Comparison of [3H]tamsulosin and [3H]prazosin binding to wild-type and constitutively active alpha1B-adrenoceptorsP Hein, M Goepel, S Cotecchia, et al.

Biochemical Pharmacology|October 1, 1987

Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonistsM C Michel, A Rother, C Hiemke, et al.

The Journal of Endocrinology|September 1, 1985

Time-dependent effects of oestradiol and progesterone on hypothalamic catecholamine turnover in ovariectomized ratsC Hiemke, D Bruder, M C Michel, et al.

The Journal of Biological Chemistry|August 29, 1998

ATP activates cAMP production via multiple purinergic receptors in MDCK-D1 epithelial cells. Blockade of an autocrine/paracrine pathway to define receptor preference of an agonistS R Post, L C Rump, A Zambon, et al.

Pageof 35